Claim OwnershipDermDocs
Subscribed: 6Played: 69
Subscribe
Description
Revolutionizing Dermatology Education
64 Episodes
Reverse
This is the second episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, is joined by Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, as they discuss the following topics: Setting the stage for treating a patient with EB Assessing EB severity and subtype to inform treatment Expert review of the current FDA-approved treatments and Strategies to close care gaps for EB patients
This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics: Challenges in achieving treatment targets in AD Therapeutic inertia and clinical implications of inadequate response Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies
This is the first episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, is joined by Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, as they discuss the following topics: Epidemiology and prevalence of EB Burden of disease and impact on patients' quality of life Gaps and challenges for patients with EB Assessing the current knowledge of clinicians and gaps in care recommendations
This podcast episode, sponsored by Leo Pharma, features LiVDerm faculty and esteemed dermatologists Dr. Christopher Bunick, MD, PhD, and Dr. Jonathan Silverberg, MD, PhD, MPH. As experts in all things concerning eczema, our faculty discuss the differentiating features and disease burden in patients suffering from chronic hand eczema (CHE) and review the current guidance for treatment, including these specific topics: Differentiating CHE from atopic dermatitis of the hands, including triggers, pathophysiology, and clinical presentation Expert guidance for accurate diagnosis and work-up of CHE patients Challenges and limitations of current therapeutic offerings The potential of a topical novel pan-JAK inhibitor for targeted treatment of CHE
This is the first episode of a two-part miniseries, "IL-31 Inhibition for Treatment of Prurigo Nodularis" series, supported by an educational grant from Galderma and hosted by prurigo nodularis (PN) expert Dr. Shawn Kwatra, MD. This episode, "Examining the Gaps and Challenges in Diagnosing and Treating Prurigo Nodularis", featuring expert dermatologist and neuroscientist Dr. Sarina Elmariah, MD, PhD, MPH, discusses the following topics: The lack of awareness and timely, correct diagnosis of PN patients Strategies for assessing patients with PN and alleviating disease symptoms and burden Examining the current expert guidance and available therapies for treating PN Looking to the future of PN diagnosis and targeted treatment
This is the second episode of a two-part activity on "Skirting Steroids in Atopic Dermatitis", supported by an educational grant from Arcutis Biotherapeutics, Inc., and hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "New Therapies and Expert Strategies for Long-term Control", featuring expert dermatologist Dr. Jonathan Silverberg, MD, PhD, MPH, discusses the following topics: The pros and cons of steroid use in treating AD Targeted non-steroidal topical therapies approved by the FDA Relevant clinical efficacy and safety data for new and emerging non-steroidal topicals Recommendations for long-term symptom control in AD patients
This is the fifth episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?", featuring expert dermatologist Dr. Naiem Issa, MD, PhD, discusses the following topics: Mechanistic differences between JAKi and biologics for treatment of AD Clinical data supporting the safety of JAKi in head-to-head trials compared to biologics Pearls for prescribing JAKi to AD patients Strategies for choosing JAKi vs biologics based on safety and patient factors
This is the first episode of a two-part activity on "Skirting Steroids in Atopic Dermatitis", supported by an educational grant from Arcutis Biotherapeutics, Inc., and hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Dangers and Side Effects of Steroid Exposure in Treatment of AD", featuring expert dermatologist Dr. Peter Lio, MD, discusses the following topics: Side effects of topical and oral corticosteroid exposure Pearls and gaps in current guidelines for treatment of AD Identifying topical steroid withdrawal symptoms Safety and stewardship strategies for topical steroids Future of non-steroidal advanced topical therapies for AD Record Date: 8/6/2024
This is the fourth episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy", featuring expert dermatologist Dr. Ruth Ann Vleugels, MD, MPH discusses the following topics: Identifying ideal candidates for oral JAK inhibitor therapy Steps to initiate therapy and onboard new patients How to manage side effects and maintain adherence to treatment Case examples and real-world data
This is the third episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "The Quest for Itch-Free, Clear Skin in Atopic Dermatitis: New Practice-Informing Evidence", featuring expert dermatologist Dr. Jonathan Silverberg, MD, PhD, MPH, discusses the following topics: Overall impact of atopic dermatitis on patients' quality of life Overview of the role of various existing treatments for AD and expert guidelines Discussion of LEVEL UP clinical trial data comparing upadacitinib and dupilumab Defining treatment success and best practices for treatment selection www.livderm.org
This special podcast episode, developed in collaboration with UCB, features LiVDerm faculty and esteemed dermatologists Dr. Jennifer Hsiao, MD, and Dr. Hadar Lev-Tov, MD. As experts in all things hidradenitis suppurativa (HS), our faculty discuss the need for early and accurate diagnosis and assessment of patients with HS in order to prescribe treatment at the best time to achieve disease control, including the following topics: Key challenges in treating patients with moderate-to-severe HS The role of targeted, systemic therapies in HS management Defining "moderate" disease and strategies for severity assessment Defining window of opportunity and strategies for advanced treatment of HS Defining and assessing treatment response and success with targeted therapies
This is the second episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis", featuring expert dermatologist Dr. James Song, MD, discusses the following topics: Short- and long-term efficacy and safety data for JAK inhibitor therapies New topline data from the LEVEL UP trial studying upadacitinib in comparison to dupilumab for the treatment of patients aged 12 years and older with moderate-to-severe AD Head-to-head studies and real-world evidence evaluating JAK inhibitor therapies Emerging clinical developments and what's coming next in JAK inhibitor research
This is the fourth and final episode of the, "Psoriasis in Skin of Color Unplugged" series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Patient and Disease Advocacy”, featuring Jason Harris, the VP of Government Relations and Advocacy at the National Psoriasis Foundation (NPF), discusses the following topics: Patient perspective on challenges to receiving treatment for their psoriasis NPF efforts to address patient challenges and access to care issues Relevant survey and research data on disparities specific to SoC and socioeconomic status Consideration of impact on quality of life in determining access to systemic treatments If you have any questions about NPF efforts to advocate for patients with psoriasis, please reach out to Jason Harris via email at jharris@psoriasis.org or visit the NPF website.
This is the third episode of the, "Psoriasis in Skin of Color Unplugged" series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Advancing Diversity and Inclusion in Clinical Trials”, featuring expert dermatologists Dr. Andrew Alexis and Dr. Jennifer Soung, discusses the following topics: Underrepresentation of diverse patients, investigators, and trial sites in clinical studies FDA efforts to improve clinical trial diversity and education The impact that current clinical trials focusing on SOC are having on patient care High-level findings from the VISIBLE trial studying psoriasis patients of color www.LiVDerm.org
This is the second episode of the, "Psoriasis in Skin of Color Unplugged" series, hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Gaps in Diagnosis and Dermatologist Training”, featuring expert dermatologist Dr. George Han, discusses the following topics: Difference in clinical presentation of psoriasis in SoC Barriers to early and accurate diagnosis and dangers of delayed diagnosis Gaps in medical student and residency education Lack of SoC images in medical textbooks, public images, and advertising Launch date is May 7
This is the first episodes of a new series, "Psoriasis in Skin of Color Unplugged", hosted by expert dermatologist Dr. Mona Shahriari who will be discussing the gaps in care for psoriasis patients with skin of color. This episode, “Disparities and Access to Care”, featuring expert dermatologist Dr. Candrice Heath, discusses the following topics: Increased severity of psoriatic disease in patients of color Challenges associated with access to specialist care Stigma surrounding psoriasis in patients of color Gaps in culturally competent care www.LiVDerm.org
This is the first episodes of a new series hosted by expert dermatologist Dr. Christopher Bunick who will be discussing the evolving role of JAK inhibitor therapies in the management of atopic dermatitis (AD). This episode, "The Spectrum of Atopic Dermatitis and the Emerging Role of JAK Inhibitors", featuring expert dermatologist Dr. John Koo, discusses the following topics: Understanding atopic dermatitis as a spectrum disorder, phenotypes and endotypes, and heterogeneity of atopic disease Summarizing JAK inhibitor therapies, including clinical safety and efficacy and mechanism of action Comparison of JAKi to biologics and traditional systemic agents, and the evolving role of JAKi in treatment of AD LiVDerm.org
n support of Eczema Awareness Month, LiVDerm sat down with one of the nation’s top experts on atopic dermatitis, Christopher G. Bunick, MD, PhD, to discuss this widespread skin condition that affects millions worldwide. Associate professor of dermatology at Yale University School of Medicine, Dr. Bunick covers emerging targeted therapies and also looks at the concerns over their safety and efficacy. He also addresses some of the gaps that persist in treatment despite these new therapies.
In support of Eczema Awareness Month, LiVDerm sat down with one of the nation’s top experts on atopic dermatitis, Peter A. Lio, MD, to discuss this widespread skin condition that affects millions worldwide. Dr. Lio, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, focuses on caring for pediatric patients with eczema in his interview. He provides unique insight into how best to combine integrative and pharmacologic treatments.
Natasha A. Mesinkovska, MD, PhD, who spoke on the live satellite symposium "Gamechangers in Alopecia Areata" at the SBS 2023 meeting, speaks out about comorbid conditions often seen in alopecia areata patients, as well as her personal approach to treatment. Questions: We’ve heard a lot about comorbid conditions often seen in patients with alopecia areata. Do you have any pearls you’d like to share regarding screening or multidisciplinary care for patients with comorbidities? What is your personal approach to developing a treatment plan for your patients with alopecia areata? Thank you for your time today, Dr Mesinkovska. This was very informative. Is there anything else you’d like to add? Date: February 10, 2023
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
Download from Google Play
Download from App Store
United States